Cargando…
Targeted Delivery of Chemotherapy Agents Using a Liver Cancer-Specific Aptamer
BACKGROUND: Using antibody/aptamer-drug conjugates can be a promising method for decreasing toxicity, while increasing the efficiency of chemotherapy. METHODOLOGY/PRINCIPAL FINDINGS: In this study, the antitumor agent Doxorubicin (Dox) was incorporated into the modified DNA aptamer TLS11a-GC, which...
Autores principales: | Meng, Ling, Yang, Liu, Zhao, Xiangxuan, Zhang, Lucy, Zhu, Haizhen, Liu, Chen, Tan, Weihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338807/ https://www.ncbi.nlm.nih.gov/pubmed/22558072 http://dx.doi.org/10.1371/journal.pone.0033434 |
Ejemplares similares
-
Automated
Modular Synthesis of Aptamer–Drug
Conjugates for Targeted Drug Delivery
por: Wang, RuoWen, et al.
Publicado: (2014) -
Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents
por: Kim, Minhee, et al.
Publicado: (2018) -
A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy
por: Trinh, Thu Le, et al.
Publicado: (2015) -
Selection of Aptamers Specific for Adipose Tissue
por: Liu, Jun, et al.
Publicado: (2012) -
Aptamer-conjugated nanomaterials for specific cancer cell recognition and targeted cancer therapy
por: Liu, Qiaoling, et al.
Publicado: (2014)